Cardiovascular Disease in Alabaster, AL
9 verified cardiovascular disease doctors in Alabaster.
Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Clyde Elliott, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. John Mcbrayer, MD
Cardiovascular Disease
CMS Open Payments· $537.37 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$537.37
Total received
30
Transactions
13
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to John Mcbrayer do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Mullens, MD
Cardiovascular Disease
CMS Open Payments· $633.72 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$633.72
Total received
26
Transactions
12
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 67th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Mark Mullens do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Hosakote Nagaraj, MD
Cardiovascular Disease
CMS Open Payments· $5,097 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$5,097
Total received
14
Transactions
6
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Hosakote Nagaraj do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Clifton Vance, MD
Cardiovascular Disease
CMS Open Payments· $455.49 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$455.49
Total received
15
Transactions
8
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 62th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Clifton Vance do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Krishna Gaddam, MD
Cardiovascular Disease
CMS Open Payments· $607.91 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$607.91
Total received
15
Transactions
7
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 66th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Krishna Gaddam do not imply any wrongdoing. Many are meals, education, or research support.
Dr. David Fieno, MD
Cardiovascular Disease
CMS Open Payments· $90,093 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$90,093
Total received
147
Transactions
24
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to David Fieno do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neeraj Mehta, MD
Cardiovascular Disease
CMS Open Payments· $338.00 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$338.00
Total received
8
Transactions
6
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 59th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Neeraj Mehta do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Abilash Balmuri, MD
Cardiovascular Disease
CMS Open Payments· $213.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$213.14
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 53th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Abilash Balmuri do not imply any wrongdoing. Many are meals, education, or research support.